Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 in Insulinoma
NCT05034783Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2021
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Peking Union Medical College Hospital. Primary endpoint: Metabolic parameters at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT05034783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05034783.